Cleemput Irina, Devriese Stephan, Kohn Laurence, Devos Carl, van Til Janine, Groothuis-Oudshoorn Catharina G M, van de Voorde Carine
Belgian Health Care Knowledge Centre, Brussels, Belgium.
Health Technology and Services Research, Mira Institute, University of Twente, Enschede, Netherlands.
MDM Policy Pract. 2018 Sep 25;3(2):2381468318799628. doi: 10.1177/2381468318799628. eCollection 2018 Jul-Dec.
Multi-criteria decision analysis can improve the legitimacy of health care reimbursement decisions by taking societal preferences into account when weighting decision criteria. This study measures the relative importance of health care coverage criteria according to the Belgian general public and policy makers. Criteria are structured into three domains: therapeutic need, societal need, and new treatments' added value. A sample of 4,288 citizens and 161 policy makers performed a discrete choice experiment. Data were analyzed using multinomial logistic regression analysis. Level-independent criteria weights were determined using the log-likelihood method. Both the general public and policy makers gave the highest weight to quality of life in the appraisal of therapeutic need (0.43 and 0.53, respectively). The general public judged life expectancy (0.14) as less important than inconvenience of current treatment (0.43), unlike decision makers (0.32 and 0.15). The general public gave more weight to "impact of a disease on public expenditures" (0.65) than to "prevalence of the disease" (0.56) when appraising societal need, whereas decision makers' weights were 0.44 and 0.56, respectively. When appraising added value, the general public gave similar weights to "impact on quality of life" and "impact on prevalence" (0.37 and 0.36), whereas decision makers judged "impact on quality of life" (0.39) more important than "impact on prevalence" (0.29). Both gave the lowest weight to impact on life expectancy (0.14 and 0.21). Comparisons between the general public and policy makers should be treated with caution because the policy makers' sample size was small. Societal preferences can be measured and used as decision criteria weights in multi-criteria decision analysis. This cannot replace deliberation but can improve the transparency of health care coverage decision processes.
多标准决策分析可以通过在权衡决策标准时考虑社会偏好,提高医疗保健报销决策的合理性。本研究根据比利时普通公众和政策制定者衡量了医疗保健覆盖标准的相对重要性。标准分为三个领域:治疗需求、社会需求和新疗法的附加值。4288名公民和161名政策制定者的样本进行了离散选择实验。使用多项逻辑回归分析对数据进行分析。使用对数似然法确定与水平无关的标准权重。在评估治疗需求时,普通公众和政策制定者都给予生活质量最高权重(分别为0.43和0.53)。与决策者(0.32和0.15)不同,普通公众认为预期寿命(0.14)不如当前治疗的不便(0.43)重要。在评估社会需求时,普通公众给予“疾病对公共支出的影响”(0.65)的权重高于“疾病患病率”(0.56),而决策者的权重分别为0.44和0.56。在评估附加值时,普通公众给予“对生活质量的影响”和“对患病率的影响”相似的权重(0.37和0.36),而决策者认为“对生活质量的影响”(0.39)比“对患病率的影响”(0.29)更重要。两者都给予对预期寿命的影响最低权重(0.14和0.21)。由于政策制定者的样本量较小,普通公众和政策制定者之间的比较应谨慎对待。社会偏好可以在多标准决策分析中进行衡量并用作决策标准权重。这不能取代审议,但可以提高医疗保健覆盖决策过程的透明度。